Business Wire6h
Contineum Therapeutics Expands Clinical Development of PIPE-791 With FDA Authorization of Its Investigational New Drug (IND) Application for Chronic Pain
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...
Experimental oxytocin-based drug offers new hope for gut disorders
University of Queensland researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that is based on the peptide hormone oxytocin that drives childbirth contractions ...
The six best treatments for gum disease
Until my mid-40s, my approach to gum health was, at best, sporadic. I had always suspected that flossing was one of those ...
News Medical on MSN12h
New oral painkiller developed for chronic abdominal pain
University of Queensland researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that ...